Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 4.64 is 14% above its 5-year average of 4.08, near the low end of its 5-year range (0.69–32.43).
As of the fiscal period ended Tuesday, June 30, 2026. 17.07% above its 12-month average of 3.96.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.64.
CURRENT RATIO
4.64
CURRENT RATIO AVG TTM
3.96
CURRENT RATIO AVG 3Y
3.79
CURRENT RATIO AVG 5Y
4.08
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+17.07%
CURRENT VS 3Y AVG
+22.50%
CURRENT VS 5Y AVG
+13.79%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 571 covered companies
CURRENT VS SECTOR MEDIAN
+38.42%
vs the sector median at left
Bluejay Diagnostics, Inc.
Market Cap
$833048.00
Current Ratio
4.64
TTM Avg
3.96
3Y Avg
3.79
5Y Avg
4.08
Market Cap
$880673.00
Current Ratio
1.83
TTM Avg
2.05
3Y Avg
3.13
5Y Avg
5.42
Market Cap
$874595.00
Current Ratio
8.67
TTM Avg
12.04
3Y Avg
7.97
5Y Avg
19.74
Market Cap
$1.02M
Current Ratio
7.99
TTM Avg
0.13
3Y Avg
1.02
5Y Avg
1.02
Market Cap
$1.11M
Current Ratio
3.86
TTM Avg
3.42
3Y Avg
2.60
5Y Avg
2.60
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | $833048.00 | 4.64 | 3.96 | 3.79 | 4.08 |
| Decoy Therapeutics Inc. (DCOY)vs › | $880673.00 | 1.83 | 2.05 | 3.13 | 5.42 |
| GlucoTrack, Inc. (GCTK)vs › | $893920.00 | 0.46 | 3.06 | 2.92 | 4.37 |
| Bone Biologics Corporation (BBLG)vs › | $874595.00 | 8.67 | 12.04 | 7.97 | 19.74 |
| CDT Equity Inc. (CDT)vs › | $685794.00 | 2.14 | 1.09 | 1.79 | 1.48 |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | 7.99 | 0.13 | 1.02 | 1.02 |
| HCW Biologics Inc. (HCWB)vs › | $566655.00 | 0.06 | 0.15 | 3.14 | 7.02 |
| Clearmind Medicine Inc. (CMND)vs › | $1.10M | 4.31 | 1.47 | 1.08 | 7.17 |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.11M | 3.86 | 3.42 | 2.60 | 2.60 |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.16M | 0.66 | 1.48 | 0.74 | 0.53 |
Current Ratio
4.64
Quick Ratio
4.64
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 4.64 |
| 2026-03-31 | 2.81 |
| 2025-12-31 | 4.88 |
| 2025-09-30 | 2.92 |
| 2025-06-30 | 4.56 |
| 2025-03-31 | 2.71 |
| 2024-12-31 | 6.05 |
| 2024-09-30 | 6.26 |
| 2024-06-30 | 4.38 |
| 2024-03-31 | 2.26 |
| 2023-12-31 | 1.82 |
| 2023-09-30 | 2.33 |
| 2023-06-30 | 3.59 |
| 2023-03-31 | 6.27 |
| 2022-12-31 | 7.19 |
| 2022-09-30 | 9.15 |
| 2022-06-30 | 17.41 |
| 2022-03-31 | 14.75 |
| 2021-12-31 | 32.43 |
| 2021-09-30 | 0.69 |
| 2021-06-30 | 0.84 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 0.57 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
